SCHEMBL5746789

SCHEMBL5746789

Cc1ccccc1C1C(N(C)C)CCCN1C(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 4/20 0.43
HSP90AB1 P08238 4/20 0.43
ITGB3 P05106 1/20 0.41
ITGB1 P05556 1/20 0.41
ITGAV P06756 1/20 0.41
ITGA5 P08648 1/20 0.41
ITGA4 P13612 1/20 0.41
RIPK1 Q13546 1/20 0.40
PROKR1 Q8TCW9 1/20 0.39
PKM P14618 1/20 0.38
OPRK1 P41145 1/20 0.38
ALDH1A1 P00352 1/20 0.36
ABCB11 O95342 1/20 0.36
HTR1A P08908 1/20 0.36
CHRM1 P11229 1/20 0.36
AVPR2 P30518 1/20 0.36
OXTR P30559 1/20 0.36
SLC6A4 P31645 1/20 0.36
ADRA1A P35348 1/20 0.36
OPRM1 P35372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5746786 1.00 HSP90AA1 (0.43) HSP90AA1HSP90AB1ITGB3ITGB1ITGAV
SCHEMBL6310123 0.84 HSP90AA1 (0.44) HSP90AA1HSP90AB1ITGB3ITGB1ITGAV
SCHEMBL5747935 0.84 HSP90AA1 (0.44) HSP90AA1HSP90AB1ITGB3ITGB1ITGAV
SCHEMBL5747527 0.83 RIPK1 (0.50) HSP90AA1HSP90AB1RIPK1PKMALDH1A1
SCHEMBL5747529 0.83 RIPK1 (0.50) HSP90AA1HSP90AB1RIPK1PKMALDH1A1
SCHEMBL5747743 0.83 TACR1 (0.43) RIPK1
SCHEMBL6317365 0.80 HSP90AA1 (0.44) HSP90AA1HSP90AB1ITGB3ITGB1ITGAV
SCHEMBL6317372 0.80 HSP90AA1 (0.44) HSP90AA1HSP90AB1ITGB3ITGB1ITGAV
SCHEMBL6312120 0.79 ITGB3 (0.44) HSP90AA1HSP90AB1ITGB3ITGB1ITGAV
SCHEMBL5744524 0.78 RIPK1 (0.39) HSP90AA1HSP90AB1ITGB3ITGB1ITGAV

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1638935-A1 NK1 ANTAGONIST Pfizer Products Inc. (US) 2006-03-29 EP disclosed
US-20050043354-A1 NK1 antagonist PFIZER INC 2005-02-24 US disclosed
WO-2004110996-A1 NK1 ANTAGONIST PFIZER PRODUCTS INC. (US) 2004-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043354-A1 NK1 antagonist TACR2, TACR1, TAC3 HSP90AA1 3787/4885HSP90AB1 3339/4885ITGB3 1995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.